What's New

SIR Foundation Pilot Grant returns high rewards for grant recipient

Donors are the life-blood of the SIR Foundation, as exemplified by the amazing research our grants programs have funded. One doctor shared his journey since receiving a foundation grant 15 years ago: Sanjay Misra, MD, FSIR, received the SIR Foundation Pilot Research Grant, which allowed him to secure funding for his initial NIH research grant. As a consequence of the initial funding, the U.S. Food and Drug Administration (FDA) authorized his investigational new drug (IND) for the use of stem cells to reduce vascular injury. Dr. Misra will be enrolling patients as part of a phase 1 study at the Mayo Clinic this summer. “The return on investment was good, with more than $4 million in funding, more than 90 papers published and a clinical trial,”Dr. Misra said. To donate, please click here. See the full story this fall in IR Quarterly.

2016 off to a great start for research

This year is off to a great start for IR research thanks to the incredible support of hundreds of donors. Attendees of the 2016 Gala made the April 3 event the most successful to date, raising more than $460,000. You can be a part of the effort to further IR innovation with your own giving—whether it is through the Pioneer Circle, Annual Fund or the new Legacy Circle. We thank all of you who have supported SIR Foundation and encouraged others to do the same.

IR Quality Toolkit

SIR has developed an IR Quality Toolkit to guide the interventional radiologist’s efforts in the implementation of quality improvement systems designed to maintain a high degree of quality and patient safety. [read more]

Did you donate? Tell a friend…spread the word

SIR Foundation has passionately encouraged innovation for more than 20 years. As we seek to expand the impact of the foundation’s annual fund, we ask your help reaching new donors and raising awareness and through your continued generous support. For ideas on how to help spread the word, please contact Michelle Lockwood, development manager, at mlockwood@sirweb.org or (703) 460-5598.


On behalf of its steering committee, Principal Investigator Suresh Vedantham is pleased to announce that the NIH-sponsored Acute Venous Thrombosis: Thrombus Removal with Adjunctive Catheter-Directed Thrombolysis (ATTRACT) Study has completed accrual of its originally planned cohort of 692 patients. ATTRACT, which enrolled patients in 56 hospitals, will determine if the use of pharmacomechanical catheter-directed thrombolysis in patients with acute proximal deep vein thrombosis (DVT) prevents the post-thrombotic syndrome and improves quality of life.

Learn more about the history of the ATTRACT trial.

SIR Foundation Pioneer Circle continues to grow

The Pioneer Circle has raised more than $160,000 for IR research and education. Will you help us continue this progress by becoming a Pioneer Circle member?